Lb Pharmaceuticals (LBRX) EPS (Weighted Average and Diluted) (2024 - 2026)
Lb Pharmaceuticals' quarterly EPS (Weighted Average and Diluted) came in at -$0.67 in Q1 2026, up 95.47% year-on-year from -$0.34 in Q1 2025, and down 121.41% quarter-over-quarter from $3.13 in Q4 2025.
Lb Pharmaceuticals has reported EPS (Weighted Average and Diluted) for 3 years, with the latest figure at -$0.67 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 95.47% year-over-year to -$0.67; the trailing twelve-month figure through Mar 2026 stood at -$12.94 (changed N/A YoY), and the FY2025 full-year result was -$3.13, up 98.22% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.67, down from $3.13 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $3.13 in Q4 2025, with the low at -$39.49 in Q3 2024.
- Average EPS (Weighted Average and Diluted) over 3 years is -$11.07, with a median of -$7.34 recorded in 2024.
- Year-over-year, EPS (Weighted Average and Diluted) jumped 122.36% in 2025 and jumped 95.47% in 2026.
- Tracing LBRX's EPS (Weighted Average and Diluted) over 3 years: stood at -$14.0 in 2024, then soared by 122.36% to $3.13 in 2025, then plunged by 121.41% to -$0.67 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.67 (Q1 2026), $3.13 (Q4 2025), and -$0.61 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 4.02 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 6.75 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.51 |
| 10 | Lb Pharmaceuticals | 789.92 Mn | 789.92 Mn | - | -0.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.67 |
| Dec 31, 2025 | 3.13 |
| Sep 30, 2025 | -0.61 |
| Mar 31, 2025 | -14.79 |
| Dec 31, 2024 | -14.00 |
| Sep 30, 2024 | -39.49 |